Northwire Canada EditionSaturday, July 18, 2026
Sign inSubscribe
Northwire
⌕
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%
M&A / Property

FendX Files Provisional Patent for Novel Antimicrobial Nanoparticle Liquid Coating

By The Northwire Desk — AI Analysis Oct 22, 2025 · 06:01 FNDX · 0.64 FendX Technologies Inc.
FNDX · Price

Executive Summary

  • FendX Technologies Inc. filed a provisional patent application (U.S. Application No. 63/936,328) for an “Antimicrobial Coating for Long‑Lasting Pathogen Control on High‑Touch Surfaces.”
  • The patented technology is a nanoparticle liquid coating that can be applied with rollers or brushes to provide sustained antimicrobial protection.
  • Management indicated the company is evaluating scale‑up and distribution partnership opportunities to commercialize the coating.

Key Details

  • Patent filing: Provisional application filed August 7, 2025; title “Antimicrobial Coating for Long‑Lasting Pathogen Control on High‑Touch Surfaces”; U.S. Patent & Trademark Office Application No. 63/936,328.
  • Inventors / Assignee: Drs. Carolyn Myers, Tohid Didar, Leyla Soleymani, Sara Moetakef Imani; assignee is FendX Technologies Inc.
  • Technology description: Nanoparticle liquid coating (formerly “spray technology”) designed for easy application via roller or brush; provides long‑lasting antimicrobial activity on high‑touch surfaces.
  • Strategic significance: Adds to FendX’s portfolio of hygiene‑related technologies, complementing existing products such as REPELWRAP™ film and catheter coatings.
  • Commercialization plan: Company is actively assessing scale‑up processes and seeking distribution partnerships to bring the coating to market.
  • Management comment: “We are pleased with the progress of our development efforts on this liquid coating technology which have resulted in the filing of this patent application,” said Dr. Carolyn Myers, CEO.

Notable Quotes

“We are now actively assessing scale‑up and distribution partnership opportunities to bring this technology to the market. This innovation underscores FendX's commitment to developing scalable solutions aimed at reducing infection risk.” – Dr. Carolyn Myers, CEO

Materiality Assessment: Non‑Material – Positive (patent filing is a forward‑looking development without immediate financial impact).

Read the original news release →

More from FendX Technologies Inc.

Apr 29, 2026 · 18:01

Regulatory Clarity on Catheter Program Fails to Halt Steep Valuation Erosion Amidst Liquidity Strain

Production / Operations Apr 15, 2026 · 07:01

FendX Pivots Manufacturing Strategy Amidst Partnership Exit

Production / Operations Apr 10, 2026 · 17:42

FendX Settles Debt with Equity at Discount Amidst Cash Flow Constraints

Financings Mar 31, 2026 · 07:01

FendX Pivots to Liquid Coatings and Settles Debt in Shares as Stock Tests Lows

Other Jan 22, 2026 · 17:01

FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents

Other Jan 16, 2026 · 12:06

Canadian Securities Exchange Reports Strong 2025 Performance Figures

Production / Operations